These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19856271)

  • 21. Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives.
    Otto M; Süssmuth R; Vuong C; Jung G; Götz F
    FEBS Lett; 1999 May; 450(3):257-62. PubMed ID: 10359085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insight into pleiotropic regulators Agr and Sar: molecular probes paving the new way for antivirulent therapy.
    Arya R; Princy SA
    Future Microbiol; 2013 Oct; 8(10):1339-53. PubMed ID: 24059923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Agr function is upregulated by photodynamic therapy for Staphylococcus aureus and is related to resistance to photodynamic therapy.
    Park HJ; Moon YH; Yoon HE; Park YM; Yoon JH; Bang IS
    Microbiol Immunol; 2013 Aug; 57(8):547-52. PubMed ID: 23668640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.
    Balaban N; Goldkorn T; Nhan RT; Dang LB; Scott S; Ridgley RM; Rasooly A; Wright SC; Larrick JW; Rasooly R; Carlson JR
    Science; 1998 Apr; 280(5362):438-40. PubMed ID: 9545222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment.
    Ribeiro PD; Ribeiro OD; Marcolan AM; Medina-Acosta E
    Peptides; 2003 Nov; 24(11):1829-36. PubMed ID: 15019216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation.
    Tsang LH; Daily ST; Weiss EC; Smeltzer MS
    Infect Immun; 2007 Sep; 75(9):4528-33. PubMed ID: 17548479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordinated and differential control of aureolysin (aur) and serine protease (sspA) transcription in Staphylococcus aureus by sarA, rot and agr (RNAIII).
    Oscarsson J; Tegmark-Wisell K; Arvidson S
    Int J Med Microbiol; 2006 Oct; 296(6):365-80. PubMed ID: 16782403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of exoprotein gene expression by the Staphylococcus aureus cvfB gene.
    Matsumoto Y; Kaito C; Morishita D; Kurokawa K; Sekimizu K
    Infect Immun; 2007 Apr; 75(4):1964-72. PubMed ID: 17283102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Staphylococcus aureus pathogenesis in vitro and in vivo by RAP-binding peptides.
    Yang G; Cheng H; Liu C; Xue Y; Gao Y; Liu N; Gao B; Wang D; Li S; Shen B; Shao N
    Peptides; 2003 Nov; 24(11):1823-8. PubMed ID: 15019215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biphasic intracellular expression of Staphylococcus aureus virulence factors and evidence for Agr-mediated diffusion sensing.
    Shompole S; Henon KT; Liou LE; Dziewanowska K; Bohach GA; Bayles KW
    Mol Microbiol; 2003 Aug; 49(4):919-27. PubMed ID: 12890018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure, activity and evolution of the group I thiolactone peptide quorum-sensing system of Staphylococcus aureus.
    MDowell P; Affas Z; Reynolds C; Holden MT; Wood SJ; Saint S; Cockayne A; Hill PJ; Dodd CE; Bycroft BW; Chan WC; Williams P
    Mol Microbiol; 2001 Jul; 41(2):503-12. PubMed ID: 11489134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
    Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
    Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease.
    Baldry M; Nakamura Y; Nakagawa S; Frees D; Matsue H; Núñez G; Ingmer H
    J Infect Dis; 2018 Aug; 218(6):1009-1013. PubMed ID: 29733353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the regulatory loci agr, sarA and sae of Staphylococcus aureus on the induction of alpha-toxin during device-related infection resolved by direct quantitative transcript analysis.
    Goerke C; Fluckiger U; Steinhuber A; Zimmerli W; Wolz C
    Mol Microbiol; 2001 Jun; 40(6):1439-47. PubMed ID: 11442841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of the response regulator AgrA in the cytosolic fraction of Staphylococcus aureus by monoclonal antibodies.
    Morfeldt E; Panova-Sapundjieva I; Gustafsson B; Arvidson S
    FEMS Microbiol Lett; 1996 Oct; 143(2-3):195-201. PubMed ID: 8837472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SarA level is a determinant of agr activation in Staphylococcus aureus.
    Chien Y; Manna AC; Cheung AL
    Mol Microbiol; 1998 Dec; 30(5):991-1001. PubMed ID: 9988476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
    Anguita-Alonso P; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Saba V; Scalise G; Sevo M; Tuzova M; Patel R; Balaban N
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2594-6. PubMed ID: 17116671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The target of RNAIII-activating protein (TRAP) from Staphylococcus aureus: purification, crystallization and preliminary X-ray analysis.
    Han YH; Kim YG; Kim DY; Ha SC; Lokanath NK; Kim KK
    Biochim Biophys Acta; 2005 Apr; 1748(1):134-6. PubMed ID: 15752702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
    Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
    J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative stress resistance and fitness-compensatory response in vancomycin-intermediate
    Tan XE; Neoh HM; Cui L; Hiramatsu K; Jamal R
    Can J Microbiol; 2019 Aug; 65(8):623-628. PubMed ID: 31063703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.